Asia Pacific Diagnostic Tests Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 160,573.05 Million |
 Market Size (Forecast Year) |
USD 351,784.56 Million |
 CAGR |
% |
| Major Markets Players |
>亚太诊断测试市场，按类型（葡萄糖测试、传染病测试、细胞学测试、CBC 测试、血培养测试、梅毒测试、尿素测试、C 反应蛋白测试、抗原测试、HBA1C 测试、妊娠测试、血脂谱测试、电解质测试、肝功能测试、粪便幽门螺杆菌测试、钙测试、交叉配型测试、甲状腺功能测试、粪便显微镜检查、尿液显微镜检查、单位包装 RBCS 测试、ESR 测试和其他测试）、解决方案（服务和产品）、技术（基于免疫测定、基于 PCR、下一代基因测序、基于光谱、基于色谱、微流体、基质技术和其他）、测试模式（基于处方的测试和 OTC 测试）、方法（分子诊断仪器、体外诊断仪器和即时诊断仪器）、样本类型（尿液、唾液、血液、头发、汗液和其他）、应用（心脏病学、肿瘤学、神经病学、骨科、胃肠病学、妇科、牙科和其他）、测试类型（生物化学、血液学、微生物学、组织病理学和其他）、年龄（儿科、成人和老年科）、最终用户（医院、诊断中心、研究实验室和研究所、研究所、家庭护理、血库、专科诊所、门诊手术中心和其他）、分销渠道（直接招标、零售和在线销售）——行业趋势和预测到 2030 年。
亚太诊断测试市场分析和规模
根据世界卫生组织 (WHO) 的数据，到 2021 年 4 月，慢性病每年将导致约 4100 万人死亡，占全球死亡人数的 71%。因此，诊断测试已被证明可用于管理慢性病状况以及疾病预防、检测和诊断。通过识别个人风险因素和早期预警指标，临床诊断为早期预防和干预开辟了新途径。因此，随着慢性病患病率的上升，预计整体市场将会增长。
Data Bridge Market Research 分析，诊断测试市场在 2022 年为 1605.7305 亿美元，预计到 2030 年将达到 3517.8456 亿美元，在 2023 年至 2030 年的预测期内复合年增长率为 10.3%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。
亚太诊断测试市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021（可定制为 2015 - 2020） |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
Type (Glucose Test, Infectious Diseases Test, Cytology Test, CBC Test, Blood Culture Test, Syphilis Test, Urea Test, C-Reactive Protein Test, Antigen Test, HBA1C Test, Pregnancy Test, Lipid Profile Test, Electrolytes Test, Liver Function Test, Stool Helicobacter Pylori Test, Calcium Test, Crossmatch Test, Thyroid Function Test, Stool Microscopy Test, Urine Microscopy Test, Unit Packed RBCS Test, ESR Test and Others Test), Solutions (Services and Products), Technology (Immunoassay-Based, PCR-Based, Next Gene Sequencing, Spectroscopy-Based, Chromatography-Based, Microfluidics, Substrate Technology and Others), Mode of Testing (Prescription-Based Testing and OTC Testing), Approach (Molecular Diagnostic Instrument, In-Vitro Diagnostic Instrument and Point Of Care Testing Instrument), Sample Type (Urine, Saliva, Blood, Hair, Sweat and Others), Application (Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology, Odontology and Others), Testing Type (Biochemistry, Haematology, Microbiology, Histopathology and Others), Age (Pediatric, Adult and Geriatric), End User (Hospitals, Diagnostic Center, Research Labs and Institutes, Research Institute, Homecare, Blood Banks, Specialty Clinics, Ambulatory Surgical Centers and Others), Distribution Channel (Direct Tenders, Retail Sales and Online Sales) |
|
Countries Covered |
China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC) |
|
Market Players Covered |
F-Hoffman La-Roche Ltd. (Switzerland), ABBOTT (U.S.), Danaher (U.S.), B.D. (U.S.), Thermo Fisher Scientific Inc. (U.S.), ACON Laboratories Inc. (U.S.), Hemosure, Inc. (U.S.), MicroGen Diagnostics (U.S.), QIAGEN (Germany), Grifols, S.A (Spain), BODITECH MED INC. (South Korea), Chembio Diagnostic Systems, Inc. (U.S.), Nanoentek (South Korea), DiaSorin S.p.A. (Italy), Bio-Rad Laboratories, Inc. (U.S.), BIOMEDOMICS INC (U.S.), EKF Diagnostics Holdings plc (U.K.), Siemens Healthcare GmbH (Germany), PerkinElmer Inc. (U.S.), BIOMÉRIEUX (France), ARKRAY USA, Inc. (U.S.), Biohit Oyj (Finland), Germaine Laboratories, Inc. (U.S.), Quidel Corporation (U.S.), Illumina, Inc. (U.S.), Lamdagen Corporation (U.S.), LifeSign LLC. (U.S.), Medixbiochemica (Finland), Nova Biomedical (U.S.), Ortho Clinical Diagnostics (U.S.), Sannuo Biosensing Co., Ltd. (U.S.), STRECK (U.S.), Sysmex Corporation (Japan), among others |
|
Market Opportunities |
|
Market Definition
Diagnostic tests are medical tests that are used to aid in the detection or diagnosis of any disease. These tests are critical in disease control, surveillance, and prevention. These tests help improve patient care, consumer safety, and healthcare spending. A diagnostic test is one that is used to determine the cause of a condition. A diagnostic test used as part of a medical examination may be used to determine the cause of symptoms or to identify a disease. A diagnostic test can be used to identify specific strengths and weaknesses when used for other purposes.
Asia-Pacific Diagnostic Tests Market Dynamics
Drivers
- Growing incidences of infectious and chronic diseases
Infectious diseases and chronic conditions are weighing heavily on the world's population. Microorganisms cause infectious diseases such as diphtheria, ebola, flu, hepatitis, HIV/AIDS, HPV, tuberculosis, and others, and sudden outbreaks such as dengue, Zika virus, COVID-19, and Swine flu drive international demand for clinical diagnostic tests. Furthermore, chronic disorders such as various types of cancers, diabetes, cardiovascular diseases, obesity, and many others are increasing the demand for clinical diagnostics.
- Rising clinical diagnostic tests
Clinical diagnostic tests are the most precise methods for identifying and characterizing microorganisms. A practical test must be accurate, quick, and capable of determining the level of infection. Better testing determines the organism's strain and drug susceptibility more quickly, reducing the time it takes to find the right antibiotic. According to a World Health Organization (WHO) report published in 2018, tuberculosis (T.B.) was one of the top ten causes of death worldwide. This is likely to be a significant market growth factor. The availability and accessibility to better diagnostic procedures are primarily responsible for the high incidence of cancer cases in living standards. Clinical cancer diagnostics equipment is widely used in these procedures, so demand of diagnostic tests are rise during the forecast period.
Opportunities
- Growing demand for advanced diagnostic solutions
Clinical diagnostics are used to manage the health of patients. It allows for the detection of diseases at an earlier stage and aids in the progression of illnesses. Furthermore, it may help infected people avoid long-term consequences, raising public awareness of the importance of clinical diagnosis. Increased healthcare spending and health awareness promote market expansion. The demand for clinical diagnostic kits is expected to rise during the forecast period as people become more concerned about the risk of disease transmission from infected patients. Diagnostic testing can be performed with the help of either services or tools and supplies. This feature will most likely improve patient convenience, which will benefit the market.
Restraints/Challenges
- Non-affordability for diagnostics tests
Pricing pressure from reimbursement cuts and budget constraints, as well as stringent regulatory policies, are expected to hamper the market growth. In addition, the diagnostic tests market is expected to be challenged by a lack of alignment with definitive central lab methods and inadequate adoption of POC devices in professional settings during the forecast period of 2023-2030.
This diagnostic tests market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the diagnostic tests market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on the Diagnostic Tests Market
COVID-19 had a negative impact on the diagnostic tests market because lab testing has increased, causing demand to increase even faster to keep up with suspected COVID-19 cases. According to the Atlantic Monthly Group, the COVID-19 test count increased dramatically worldwide, from 760,441 tests in September 2020 to 964,792 new tests in October 2020. As a result, the increasing number of tests due to the ongoing increase in patients and government financing is expected to drive demand for COVID-19 test kits and fuel the overall market's exponential growth.
Recent developments
- In March 2020, Siemens Healthcare GmbH officially announced the RAPIDPoint 500e Blood Gas Analyzer launch, which expanded the company's product portfolio and is also used in COVID-19 efforts. This assists in increasing revenue from the line.
- In March 2020, Siemens Healthcare GmbH and the Marienhaus Hospital Group announced a ten-year partnership. This collaboration will benefit the company in the long run in diagnostics. This agreement will also improve the company's financials.
Asia-Pacific Diagnostic Tests Market Scope
The diagnostic tests market is segmented on the basis of type, solution, technology, mode of testing, approach, sample type, application, testing type, age, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Glucose Test
- Infectious Diseases Test
- Cytology Test
- CBC Test
- Blood Culture Test
- Syphilis Test
- Urea Test
- C-Reactive Protein Test
- Antigen Test
- HBA1C Test
- Pregnancy Test
- Lipid Profile Test
- Electrolytes Test
- Liver Function Test
- Stool Helicobacter Pylori Test
- Calcium Test, Crossmatch Test
- 甲状腺功能检查
- 粪便显微镜检查
- 尿液显微镜检查
- 单位包装红细胞检测
- ESR 测试及其他测试
解决方案
- 服务
- 产品
技术
- 基于免疫测定
- 基于PCR
- 下一代基因测序
- 基于光谱的
- 基于色谱法
- 微流体
- 基板技术
- 其他的
测试方式
- 基于处方的测试
- OTC测试
方法
- 分子诊断仪器
- 体外诊断仪器
- 即时诊断测试仪器
样品类型
- 尿
- 唾液
- 血
- 头发
- 汗
- 其他的
应用
- 心脏病学
- 肿瘤学
- 神经病学
- 骨科
- 胃肠病学
- 妇科
- 牙科
- 其他的
测试类型
- 生物化学
- 血液学
- 微生物学
- 组织病理学
- 其他的
年龄
- 儿科
- 成人
- 老年
最终用户
- 医院、诊断中心
- 研究实验室和研究所
- 研究所
- 家庭护理
- 血库
- 专科诊所
- 门诊手术中心
- 其他的
分销渠道
- 直接招标
- 零售销售
- 网上销售
亚太地区诊断测试市场区域分析/见解
对诊断测试市场进行分析，并按国家、类型、解决方案、技术、测试模式、方法、样本类型、应用、测试类型、年龄、最终用户和分销渠道提供市场规模洞察和趋势。
诊断测试市场报告涵盖的国家包括亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 其他地区
预计亚太地区将在 2023 年至 2030 年间实现最快增长，这得益于针对特定肿瘤和癌症患者的个性化医疗需求增加以及临床前研究中诊断测试的广泛使用。由于政府和私营部门的战略举措，中国正引领亚太市场的增长。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和诊断测试市场份额分析
诊断测试市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对诊断测试市场的关注有关。
诊断测试市场的一些主要参与者包括：
- F-Hoffman La-Rcohe 有限公司（瑞士）
- 雅培（美国）
- 丹纳赫（美国）
- BD（美国）
- 赛默飞世尔科技公司（美国）
- ACON Laboratories Inc.（美国）
- Hemosure, Inc.（美国）
- MicroGen Diagnostics（美国）
- QIAGEN（德国）
- Grifols, SA（西班牙）
- BODITECH MED INC.（韩国）
- Chembio Diagnostic Systems, Inc.（美国）
- Nanoentek（韩国）
- DiaSorin SpA（意大利）
- Bio-Rad Laboratories, Inc.（美国）
- BIOMEDOMICS INC（美国）
- EKF Diagnostics Holdings plc（英国）
- 西门子医疗有限公司（德国）
- PerkinElmer Inc.（美国）
- 生物梅里埃（法国）
- ARKRAY USA, Inc.（美国）
- Biohit Oyj（芬兰）
- Germaine Laboratories, Inc.（美国）
- Quidel Corporation（美国）
- Illumina 公司（美国）
- Lamdagen Corporation（美国）
- LifeSign LLC.（美国）
- Medixbiochemica（芬兰）
- Nova Biomedical（美国）
- Ortho Clinical Diagnostics（美国）
- 三诺生物传感有限公司（美国）
- STRECK（美国）
- Sysmex 公司 (日本)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
